CytoDyn submits first part of biologics license application to FDA for flagship HIV drug leronlimab
1 Mins read
Reading Time: < 1 minuteCytoDyn Inc (OTCMKTS:CYDY), a Vancouver-based biotech announced Monday that it has filed the non-clinical portion of a Biologics License Application for its flagship…
